509 related articles for article (PubMed ID: 34538213)
1. Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
Madden EF; Prevedel S; Light T; Sulzer SH
Subst Use Misuse; 2021; 56(14):2181-2201. PubMed ID: 34538213
[TBL] [Abstract][Full Text] [Related]
2. Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults.
Jaffe K; Slat S; Chen L; Macleod C; Bohnert A; Lagisetty P
J Subst Use Addict Treat; 2024 Aug; 163():209361. PubMed ID: 38703949
[TBL] [Abstract][Full Text] [Related]
3. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
[No Abstract] [Full Text] [Related]
4. A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
Cioe K; Biondi BE; Easly R; Simard A; Zheng X; Springer SA
J Subst Abuse Treat; 2020 Dec; 119():108146. PubMed ID: 33138929
[TBL] [Abstract][Full Text] [Related]
5. Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers.
Pasman E; Lee G; Kollin R; Rodriguez B; Agius E; Madden EF; Resko SM
Subst Use Misuse; 2022; 57(12):1828-1836. PubMed ID: 36041008
[No Abstract] [Full Text] [Related]
6. Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder.
Randall-Kosich O; Andraka-Christou B; Totaram R; Alamo J; Nadig M
J Addict Med; 2020; 14(4):e44-e52. PubMed ID: 31651562
[TBL] [Abstract][Full Text] [Related]
7. Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
Pilarinos A; Bromberg DJ; Karamouzian M
JAMA Pediatr; 2022 Mar; 176(3):304-311. PubMed ID: 34870707
[TBL] [Abstract][Full Text] [Related]
8. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
[No Abstract] [Full Text] [Related]
9. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
[TBL] [Abstract][Full Text] [Related]
10. Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.
Viera A; Bromberg DJ; Whittaker S; Refsland BM; Stanojlović M; Nyhan K; Altice FL
Epidemiol Rev; 2020 Jan; 42(1):41-56. PubMed ID: 32239206
[TBL] [Abstract][Full Text] [Related]
11. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.
Andraka-Christou B; Totaram R; Randall-Kosich O
Subst Abus; 2022; 43(1):415-424. PubMed ID: 34214400
[No Abstract] [Full Text] [Related]
12. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA
Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967
[TBL] [Abstract][Full Text] [Related]
13. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
Andraka-Christou B; Atkins D
Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
[TBL] [Abstract][Full Text] [Related]
14. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
Brezel ER; Powell T; Fox AD
Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
[TBL] [Abstract][Full Text] [Related]
15. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
[TBL] [Abstract][Full Text] [Related]
16. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
17. Effects of Bundling Medication for Opioid Use Disorder With an mHealth Intervention Targeting Addiction: A Randomized Clinical Trial.
Gustafson DH; Landucci G; Vjorn OJ; Gicquelais RE; Goldberg SB; Johnston DC; Curtin JJ; Bailey GL; Shah DV; Pe-Romashko K; Gustafson DH
Am J Psychiatry; 2024 Feb; 181(2):115-124. PubMed ID: 37789744
[TBL] [Abstract][Full Text] [Related]
18. Health professionals' attitudes toward medications for opioid use disorder.
Brown AR
Subst Abus; 2022; 43(1):598-614. PubMed ID: 34520703
[No Abstract] [Full Text] [Related]
19. Attitudes toward and training in medications for opioid use disorders: a descriptive analysis among employees in the youth legal system and community mental health centers.
O'Reilly LM; Schwartz K; Brown SA; Dir A; Gillenwater L; Adams Z; Zapolski T; Hulvershorn LA; Aalsma M
Subst Abuse Treat Prev Policy; 2024 Jun; 19(1):32. PubMed ID: 38907286
[TBL] [Abstract][Full Text] [Related]
20. Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
Haggerty T; Turiano NA; Turner T; Dekeseredy P; Sedney CL
Addict Sci Clin Pract; 2022 Dec; 17(1):72. PubMed ID: 36517926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
